Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.
Saved in:
| Title: | Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry. |
|---|---|
| Authors: | Condorelli GA; Research Centre in the Medical-Pharmaceutical Field, Department of Pharmaceutical Science, Faculty of Medicine and Pharmacy, 'Dunarea de Jos' University of Galati, Galati - Romania.; Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania - Italy., Pipoli M; Department of Legal Studies, University of Salento, Lecce - Italy., Bonifacio D; Abiogen Pharma S.p.A., Pisa - Italy., Marcellusi A; Department of Pharmaceutical Science (DISFARM), University of Milan, Milan - Italy., Paganoni L; Roche S.p.A., Monza - Italy. |
| Source: | Global & regional health technology assessment [Glob Reg Health Technol Assess] 2026 Jun 19; Vol. 13, pp. 156-166. Date of Electronic Publication: 2026 Jun 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AboutScience Country of Publication: Italy NLM ID: 9918417986506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2283-5733 (Electronic) Linking ISSN: 22842403 NLM ISO Abbreviation: Glob Reg Health Technol Assess Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2283-5733 |
|---|---|
| DOI: | 10.33393/grhta.2026.3664 |
